D-NOME
PrivateLast Round
Seed
Jan 21, 2023
Est. Valuation
$500,000
Total Funding Raised
$1.61M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
D-NOME operates in Healthcare & Life Sciences and is based in Hyderabad. Its latest recorded funding round was a Seed round in January 2023.
D-NOME is a biotechnology company that develops reagents and kits for molecular diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
D-NOME Comparables
Compare D-NOME with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OmiX Research and Diagnostics Laboratories | 84% | |
| Ramja Genosensor | 79% | |
| Papyrus Diagnostics Private Limited | 78% |
For institutional investors. Book with your work email.
D-NOME Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 21, 2023 | ||||
| Grant | Dec 1, 2021 | ||||
| Pre Seed | Sep 28, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
D-NOME Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotechnology Industry Research Assistance Council | Grant |
| Seeders | Seed |
| 3i Partners | Seed |
| Nidhi Prayas | Grant |
| Ankur Capital | Seed |
| Campus Fund | Seed |
| Hello Tomorrow | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 31% MoM.
- Jan 7, 2026
Monthly visitors grew 179% MoM, reaching 2.1K.
For institutional investors. Book with your work email.
D-NOME Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about D-NOME's valuation, stock price, and market status.
Is D-NOME a public or private company?
D-NOME is a private company.
What is the current stock price of D-NOME?
D-NOME is a private company, so its shares have no public market price. Caplight tracks D-NOME's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is D-NOME worth (valuation)?
D-NOME's valuation is estimated at $500.0K based on funding round data.
Can I buy D-NOME stock?
D-NOME shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was D-NOME's last funding round?
D-NOME's most recent funding round was Seed on January 21, 2023.
Who are the main investors in D-NOME?
Key investors in D-NOME include Ankur Capital, Entrepreneurs First.
Will D-NOME IPO soon?
No public IPO plans have been announced for D-NOME.
How can I track D-NOME secondary market activity?
Caplight tracks bids, offers, and trades in D-NOME's shares on secondary markets.